Myeloperoxidase in the neurodegenerative process of Parkinson's disease

被引：15
|
作者：
Teismann, P. [1 ]
机构：
[1] Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2014年 / 139卷 / 03期
关键词：
myeloperoxidase; Parkinson's disease; MPTP; neutrophils; Aastrocytes; gliosis; neurodegeneration; OXIDATIVE STRESS; MODEL; ACTIVATION; MICE;
D O I：
10.1055/s-0033-1359907
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Myeloperoxidase (MPO) is a hemoprotein which is involved in the unspecific immune response. In this process hypochloric acid is released. Hypochloric acid can react with lipids and proteins and thus lead to cell damage. We were able to show that MPO, as well as a biomarker for MPO - 3-Chlorotyrosine - are upregulated in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-model of Parkinson's disease as well as in the disease itself. Ablation of MPO resulted in a neuroprotective effect in the MPTP-model. Herein we describe the different function of MPO, and how these can lead to the cellular demise as seen in Parkinson's disease.
引用
收藏
页码：99 / 102
页数：4
相关论文
共 50 条
  • [41] Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
    R. Krüger
    T. Müller
    O. Riess
    Journal of Neural Transmission, 2000, 107 : 31 - 40
  • [42] The Lewy Body in Parkinson's Disease and Related Neurodegenerative Disorders
    Wakabayashi, Koichi
    Tanji, Kunikazu
    Odagiri, Saori
    Miki, Yasuo
    Mori, Fumiaki
    Takahashi, Hitoshi
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 495 - 508
  • [43] Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder
    Khan, Asmat Ullah
    Akram, Muhammad
    Daniyal, Muhammad
    Zainab, Rida
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2019, 129 (01) : 55 - 93
  • [44] Foreword: Parkinson's Disease: Progress in Neurodegenerative and Clinical Research
    W. Kuhn
    T. Müller
    P. H. Kraus
    M. Gerlach
    Journal of Neural Transmission, 2000, 107 (1) : I - I
  • [45] A Neurodegenerative Disease Sleep Questionnaire: Principal component analysis in Parkinson's disease
    Scullin, Michael K.
    Harrison, Tyler L.
    Factor, Stewart A.
    Bliwise, Donald L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 336 (1-2) : 243 - 246
  • [46] Parkinson's and Alzheimer's disease as system-wide neurodegenerative disorders
    Bartsch, Thorsten
    Berg, Daniela
    Heneka, Michael
    Leypoldt, Frank
    NERVENARZT, 2023, 94 (10): : 875 - 884
  • [47] On a New Paradigm of the Development of Neurodegenerative Diseases by the Example of Alzheimer's Disease and Parkinson's Disease
    Litvinenko, I. V.
    Lobzin, V. Yu.
    ADVANCES IN GERONTOLOGY, 2022, 12 (04) : 386 - 395
  • [48] On a New Paradigm of the Development of Neurodegenerative Diseases by the Example of Alzheimer’s Disease and Parkinson’s Disease
    I. V. Litvinenko
    V. Yu. Lobzin
    Advances in Gerontology, 2022, 12 : 386 - 395
  • [49] Vaccination Reduces Risk of Alzheimer's Disease, Parkinson's Disease, and Other Neurodegenerative Disorders
    Lehrer, Steven
    Rheinstein, Peter H.
    DISCOVERY MEDICINE, 2022, 34 (172) : 97 - 101
  • [50] Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
    Franco-Iborra, Sandra
    Vila, Miquel
    Perier, Celine
    FRONTIERS IN NEUROSCIENCE, 2018, 12
12345